139 related articles for article (PubMed ID: 10608785)
1. Echoviruses and coxsackie B viruses that use human decay-accelerating factor (DAF) as a receptor do not bind the rodent analogues of DAF.
Spiller OB; Goodfellow IG; Evans DJ; Almond JW; Morgan BP
J Infect Dis; 2000 Jan; 181(1):340-3. PubMed ID: 10608785
[TBL] [Abstract][Full Text] [Related]
2. Echoviruses bind heparan sulfate at the cell surface.
Goodfellow IG; Sioofy AB; Powell RM; Evans DJ
J Virol; 2001 May; 75(10):4918-21. PubMed ID: 11312365
[TBL] [Abstract][Full Text] [Related]
3. Characterization of echoviruses that bind decay accelerating factor (CD55): evidence that some haemagglutinating strains use more than one cellular receptor.
Powell RM; Schmitt V; Ward T; Goodfellow I; Evans DJ; Almond JW
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1707-13. PubMed ID: 9680134
[TBL] [Abstract][Full Text] [Related]
4. Development of a recombinant CHO cell model for the investigation of CAR and DAF role during early steps of echovirus 6 infection.
Renois F; Hong SS; Le Naour R; Gafa V; Talmud D; Andréoletti L; Lévêque N
Virus Res; 2011 Jun; 158(1-2):46-54. PubMed ID: 21420451
[TBL] [Abstract][Full Text] [Related]
5. Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor.
Martino TA; Petric M; Brown M; Aitken K; Gauntt CJ; Richardson CD; Chow LH; Liu PP
Virology; 1998 May; 244(2):302-14. PubMed ID: 9601501
[TBL] [Abstract][Full Text] [Related]
6. Two clusters of mutations map distinct receptor-binding sites of echovirus 11 for the decay-accelerating factor (CD55) and for canyon-binding receptors.
Rezaikin AV; Novoselov AV; Sergeev AG; Fadeyev FA; Lebedev SV
Virus Res; 2009 Oct; 145(1):74-9. PubMed ID: 19540285
[TBL] [Abstract][Full Text] [Related]
7. Antibody binding to individual short consensus repeats of decay-accelerating factor enhances enterovirus cell attachment and infectivity.
Shafren DR; Dorahy DJ; Thorne RF; Kinoshita T; Barry RD; Burns GF
J Immunol; 1998 Mar; 160(5):2318-23. PubMed ID: 9498772
[TBL] [Abstract][Full Text] [Related]
8. Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate.
Milstone AM; Petrella J; Sanchez MD; Mahmud M; Whitbeck JC; Bergelson JM
J Virol; 2005 Jan; 79(1):655-60. PubMed ID: 15596863
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of two coxsackievirus B3 strains: putative influence of virus-receptor interactions on pathogenesis.
Selinka HC; Wolde A; Pasch A; Klingel K; Schnorr JJ; Küpper JH; Lindberg AM; Kandolf R
J Med Virol; 2002 Jun; 67(2):224-33. PubMed ID: 11992583
[TBL] [Abstract][Full Text] [Related]
10. Interaction of decay-accelerating factor with coxsackievirus B3.
Hafenstein S; Bowman VD; Chipman PR; Bator Kelly CM; Lin F; Medof ME; Rossmann MG
J Virol; 2007 Dec; 81(23):12927-35. PubMed ID: 17804498
[TBL] [Abstract][Full Text] [Related]
11. Echovirus infection of rhabdomyosarcoma cells is inhibited by antiserum to the complement control protein CD59.
Goodfellow IG; Powell RM; Ward T; Spiller OB; Almond JW; Evans DJ
J Gen Virol; 2000 May; 81(Pt 5):1393-401. PubMed ID: 10769083
[TBL] [Abstract][Full Text] [Related]
12. Coxsackie B viruses that use human DAF as a receptor infect pig cells via pig CAR and do not use pig DAF.
Spiller OB; Goodfellow IG; Evans DJ; Hinchliffe SJ; Morgan BP
J Gen Virol; 2002 Jan; 83(Pt 1):45-52. PubMed ID: 11752699
[TBL] [Abstract][Full Text] [Related]
13. Cytolytic replication of coxsackievirus B2 in CAR-deficient rhabdomyosarcoma cells.
Polacek C; Ekström JO; Lundgren A; Lindberg AM
Virus Res; 2005 Nov; 113(2):107-15. PubMed ID: 15964091
[TBL] [Abstract][Full Text] [Related]
14. Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses.
Bergelson JM; Chan M; Solomon KR; St John NF; Lin H; Finberg RW
Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6245-8. PubMed ID: 7517044
[TBL] [Abstract][Full Text] [Related]
15. A single amino acid substitution controls DAF-dependent phenotype of echovirus 11 in rhabdomyosarcoma cells.
Novoselov AV; Rezaykin AV; Sergeev AG; Fadeyev FA; Grigoryeva JV; Sokolova ZI
Virus Res; 2012 Jun; 166(1-2):87-96. PubMed ID: 22445689
[TBL] [Abstract][Full Text] [Related]
16. Prevalent human coxsackie B-5 virus infects porcine islet cells primarily using the coxsackie-adenovirus receptor.
Myers SE; Brewer L; Shaw DP; Greene WH; Love BC; Hering B; Spiller OB; Njenga MK
Xenotransplantation; 2004 Nov; 11(6):536-46. PubMed ID: 15479464
[TBL] [Abstract][Full Text] [Related]
17. Human pancreatic islet endothelial cells express coxsackievirus and adenovirus receptor and are activated by coxsackie B virus infection.
Zanone MM; Favaro E; Ferioli E; Huang GC; Klein NJ; Perin PC; Peakman M; Conaldi PG; Camussi G
FASEB J; 2007 Oct; 21(12):3308-17. PubMed ID: 17494992
[TBL] [Abstract][Full Text] [Related]
18. CD59 expressed on a tumor cell surface modulates decay-accelerating factor expression and enhances tumor growth in a rat model of human neuroblastoma.
Chen S; Caragine T; Cheung NK; Tomlinson S
Cancer Res; 2000 Jun; 60(11):3013-8. PubMed ID: 10850450
[TBL] [Abstract][Full Text] [Related]
19. Decay-accelerating factor (DAF/CD55) is a functional active element of the LPS receptor complex.
Heine H; Ulmer AJ; El-Samalouti VT; Lentschat A; Hamann L
J Endotoxin Res; 2001; 7(3):227-31. PubMed ID: 11581575
[TBL] [Abstract][Full Text] [Related]
20. Enhanced cellular receptor usage by a bioselected variant of coxsackievirus a21.
Johansson ES; Xing L; Cheng RH; Shafren DR
J Virol; 2004 Nov; 78(22):12603-12. PubMed ID: 15507647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
